This report was first published by Endpoints News. To see the original version, click here
Compounded forms of the molecule behind Eli Lilly’s metabolic blockbusters Mounjaro and Zepbound that have vitamin B12 added to them may be unsafe, Lilly said Thursday.
Lilly and its fellow GLP-1-based drugmaker Novo Nordisk have both taken a stance against compounding pharmacies, which make copycats of their drugs that sometimes include other molecules such as vitamin B12 to differentiate them from the branded versions. Lilly has sued compounders in the past, as has Novo.
您已阅读16%（566字），剩余84%（2953字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。